In vitiligo, the melanocytes are lost from the skin in certain areas. One treatment for vitiligo takes the melanocytes from areas of normal skin and places them on areas of that same person's body which have lost their color. This is called the melanocyte-keratinocyte transplantation procedure (MKTP). This procedure has been used successfully in over 3000 cases in India and Saudi Arabia. The purpose of this study is to see if it is effective when performed at the investigators' institution.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
40
skin pigment cells are taken from areas of normal skin and placed on areas of that same person's body which have lost their color.
Henry Ford Medical Center, New Center One
Detroit, Michigan, United States
effectiveness of MKTP in treating vitiligo
Assessed by percent repigmentation (excellent= 100%-95%, good= 94%-65%, fair= 64%-25%, poor= 24%-0%).
Time frame: 6 months
safety of MKTP in treating vitiligo
Assessed by frequency of adverse events, including, scarring, infection, etc.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.